Bone Marrow Failure

Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases

The HOPE Biobank Resource (BMT CTN 2402 HOPE)

Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

Study to Evaluate of EXG34217 in Patients With Telomere Biology Disorders With Bone Marrow Failure

Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders

Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures

Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases

European Rare Blood Disorders Platform (ENROL)

NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia

T-cell Depleted Alternative Donor Transplantation

Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant

Identification of Autoantibodies and Autoantigens in the Cerebrospinal Fluid of Patients With Spinal Cord Trauma

CD34+ Stem Cell Infusion to Augment Graft Function

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study

Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)

Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria